The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Maclaren, Elizabeth Sara
    Director born in November 1959
    Individual (1 offspring)
    Officer
    2013-03-15 ~ dissolved
    OF - director → CIF 0
  • 2
    Ingram, David, Dr
    Director born in February 1976
    Individual (1 offspring)
    Officer
    2013-03-15 ~ dissolved
    OF - director → CIF 0
  • 3
    Taylor, Michael
    Director born in January 1966
    Individual (228 offsprings)
    Officer
    2013-03-15 ~ dissolved
    OF - director → CIF 0
  • 4
    Mr Mike Taylor
    Born in October 1966
    Individual (1 offspring)
    Person with significant control
    2017-03-01 ~ dissolved
    PE - Has significant influence or controlCIF 0
    PE - Has significant influence or control over the trustees of a trustCIF 0
    PE - Has significant influence or control as a member of a firmCIF 0
parent relation
Company in focus

HEALTHCIRCLE COMMUNICATIONS LIMITED

Previous name
CNS SCIENCE PHARMA LIMITED - 2014-12-16
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Called-up share capital not yet paid and not classified as a current asset
100 GBP2017-03-31
100 GBP2016-03-31
Net assets/liabilities including pension asset/liability
100 GBP2017-03-31
100 GBP2016-03-31
Number of shares allotted
Class 1 ordinary share
100 shares2017-03-31
Par Value of Share
Class 1 ordinary share
1 GBP2016-04-01 ~ 2017-03-31
Paid-up share capital
Class 1 ordinary share
100 GBP2017-03-31
100 GBP2016-03-31
Shareholder's fund
100 GBP2017-03-31
100 GBP2016-03-31

  • HEALTHCIRCLE COMMUNICATIONS LIMITED
    Info
    CNS SCIENCE PHARMA LIMITED - 2014-12-16
    Registered number 08447910
    446 Linen Hall, 162-168 Regent Street, London, Greater London W1B 5TD
    Private Limited Company incorporated on 2013-03-15 and dissolved on 2018-09-18 (5 years 6 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.